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Abstract
The aim of this study was to compare select aspects of exercise energy metabolism in patients with breast cancer with 
that of healthy controls across a variety of exercise intensities. Posttreated patients with breast cancer were matched 
with healthy women based on age, physical fitness level, and menopausal status. Subjects participated in low-, moderate-, 
and high-intensity submaximal exercise sessions that corresponded with 40% of maximal oxygen consumption (Vo2max), 
60% Vo2max, and 70% Vo2max. Oxygen consumption and respiratory exchange ratio were taken during submaximal exercise 
sessions to determine substrate oxidation rates for carbohydrate (CHO) and fat. Blood lactate and blood glucose were 
also measured before and after each of the submaximal exercise sessions as indices of CHO metabolism. Results indicate 
that the patients with breast cancer had a significantly (P ≤ .05) lower CHO oxidation rate and higher fat oxidation rate at 
all exercise intensities compared with healthy women. The patients with breast cancer had a significantly (P ≤ .05) lower 
blood lactate response to exercise across all intensities compared with the healthy women. Glucose responses tended (P 
< .08) to be more elevated in patients with cancer both before and after the exercise sessions. The findings indicate that 
posttreated patients with breast cancer have augmented fat metabolism and a reduced CHO-based energy metabolism 
during submaximal exercise. It is unclear whether these changes are the result of the patient’s cancer or their treatment 
regimen for the cancer.
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Introduction
Over the past 35 years, breast cancer has been the most 
prevalent type of cancer diagnosed in women in the United 
States.1 Although this disease is increasingly common, the 
mortality rate is currently decreasing and the survival rate is 
increasing.1 The decreased mortality rate can be attributed to 
earlier detection and more aggressive treatments.2-5 These 
efforts have resulted in there being more than 2.4 million 
breast cancer survivors in the United States in 2009.6
Treatment of breast cancer is multifaceted and varies indi-
vidually based on the type of tumor and individual risk fac-
tors.6 Treatment typically consists of removal of a tumor and 
adjuvant therapies such as radiation, chemotherapy, hor-
monal therapy, or any combination of these.7 Adjuvant treat-
ments for breast cancer can have many acute and long-term 
debilitating side effects, including but not limited to a 
decrease in energy expenditure, weight gain, fatigue, 
increased risk of cardiovascular disease, decreased cardio-
pulmonary function, and decreased quality of life.5,7,8
Recent studies demonstrate positive benefits of exercise 
training within breast cancer survivors.5,7-10 A review of 
studies by Kim et al5 showed that aerobic exercise training in 
patients with breast cancer during and after adjuvant thera-
pies significantly improved aerobic capacity and body com-
position. A study of postmenopausal breast cancer survivors 
involved in an exercise program saw a significant increase 
in quality of life compared with nonexercising patients in a 
control group.9 Furthermore, Sternfeld et al10 found 
Tosti et al. 7
increased amounts of physical activity, including exercise 
training, in breast cancer survivors decreased the total 
occurrence of mortality due to all causes, including cancer 
recurrence (the form of exercise training was not specified 
in this study). These positive outcomes have led exercise 
researchers to pursue further studies on the physiological 
responses to exercise and exercise training in cancer 
patients, where there is currently only paltry information.
During the past several decades, researchers have exten-
sively explored aspects of energy metabolism in normal 
healthy individuals at rest and in response to exercising at 
varying intensities. Characteristics of energy metabolism 
such as energy substrate usage (eg, glucose vs triglyceride), 
energy pathway activation (eg, glycolysis vs Krebs cycle), 
endocrine factor regulation, and energy production rates are 
well quantified and understood.11 However, there have been 
only a few studies looking at such energy metabolism issues 
in patients with cancer. Studies have shown that glucose 
intolerance was present and more frequent in cancer popu-
lations when compared with healthy controls.12,13 Larsson 
et al14 found that insulin resistance and greater levels of 
fasting insulin are also associated with breast cancer. These 
studies suggest that there seems to be some association 
between altered carbohydrate metabolism and breast cancer 
disease. Furthermore, Evans and associates15 indirectly 
examined carbohydrate metabolism during exercise by mea-
suring blood lactate responses. They found that posttreated 
patients with breast cancer had significantly lower lactate 
levels following high intensity (70% maximal oxygen con-
sumption [Vo
2max
]) exercise when compared with age-
matched healthy controls. When exercising at a higher 
intensity, there is a greater reliance on carbohydrate as an 
energy substrate and therefore more lactate is produced 
through glycolytic mechanisms.11,16,17 The lower blood lac-
tate during high-intensity exercise in breast cancer patients 
reported by Evans et al15 led us to speculate that perhaps 
less carbohydrate was being metabolized as an energy sub-
strate during exercise.
The results of the study performed by Evans and associ-
ates15 and the general lack of substantial work on energy 
metabolism during exercise in patients with cancer led us to 
pursue the current study. The purpose of this study was to 
compare substrate usage (ie, oxidation rates) and blood lac-





), and high-intensity (70% Vo
2max
) 
exercise bouts in posttreated patients with breast cancer 
versus age-matched, sedentary, healthy controls.
Methodology
Subjects
Subjects in this study were recruited into 2 groups: a treat-
ment group and a control group. The treatment group con-
sisted of posttreated patients with breast cancer who were 
newly enrolled in the Get REAL and HEEL Breast Cancer 
Program at the University of North Carolina–Chapel Hill. 
The criteria for participation in the treatment group 
included the following: women with confirmed diagnosis 
of stage I-III invasive breast cancer, within 6 months of 
completion of all major cancer treatments, ages ranging 
from 25 to 75 years (actual age range = 39-64 years), no 
presence of metastatic disease, and no presence of immune 
system deficiency that would compromise a subject’s abil-
ity to participate in regular exercise. Patients receiving 
adjuvant hormonal therapy or adjuvant trastuzumab were 
eligible to participate in the treatment group. The control 
group consisted of women who were recruited from the 
Chapel Hill town area, who had not been participating in 
regular exercise for at least 1 year, and were healthy enough 
to participate in aerobic exercise (age range = 38-66 years). 
Subjects in the control group were matched to subjects in 
the treatment group based on age, physical activity level, 
and menopausal status.
This human subjects study was reviewed and approved 
by the Institutional Review Board at University of North 
Carolina–Chapel Hill. Before agreeing to the study, all sub-
jects met with the primary investigator to go over the exper-
imental protocol. Subjects were informed of all risks 
associated with the study and then were allowed to read and 
sign the informed consent form. They were also given a 
physical activity questionnaire (PAQ; modeled after the 
modifiable activity questionnaire) assessing activity levels 
over the past year.18 Subjects completed the PAQ at the first 
meeting and scores from the questionnaire were used in 
matching the patients with breast cancer with healthy con-
trols. All patients with breast cancer were cleared by their 
oncologist to participate in physical activity whereas all 
control subjects completed a physical screening and 12-lead 
resting electrocardiogram (ECG) at our laboratory for clear-
ance to participate. All subjects were given preassessment 
guidelines to follow before any exercise testing occurred. 
Subjects were excluded from the study based on the follow-
ing criteria: an abnormal ECG, a recent history of smoking 
(quit ≤2 years ago), any known metabolic disease, acute or 
chronic illness (besides breast cancer for the treatment 
group), elevated resting vitals, physical injury, or inability 
to complete a submaximal cycle ergometer test.
Maximal Oxygen Consumption Test
Once the subjects had been cleared for participation, they 
reported to our laboratory for their first exercise test. This 
exercise test was used to predict their Vo
2max
 value. Once at 
the laboratory, subjects sat down with a researcher to 
record menstrual status and verify that preassessment 
guidelines had been followed. Subjects were fit with a heart 
rate (HR) monitor (Polar Electro, Inc, Lake Success, NY) 
and asked to rest in a seated position for 5 minutes. After 5 
minutes of quiet rest, HR, blood pressure (BP), and blood 
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oxygen saturation levels (Spo
2
; BCI International pulse 
oximeter (BCI International, Waukesha, WI) were recorded. 
Once resting HR was recorded, 70% of heart rate reserve 
(HRR) was calculated using the Karvonen formula, which 
has an associated error rate of ~5%.19 Subjects did not con-
tinue with the exercise session if any of the following rest-
ing vitals were observed: HR ≥ 100 beats per minute (bpm), 
systolic BP ≥ 140 mm Hg, diastolic BP ≥ 90 mm Hg, or 
Spo
2
 saturation ≤ 90%. Age, weight, and height were 
recorded and skin fold measurements (Lange calipers, Beta 
Technology, Santa Cruz, CA) were taken at the triceps, 
suprailiac, and abdomen to determine body composition 
using the Jackson and Pollock equation for women.19 For 
cycle ergometry, each subject was fit onto the “Lode” 
ergometer (Lode BV, Groningen, The Netherlands) and the 
seat height was adjusted so that there was a 5° to 10° bend 
in the knee of the extended leg. Subjects were also fit with 
a “Oro-Nasal 7400 Vmask” facemask (Hans Rudolph, Inc, 
Shawnee, KS) secured tightly around their head that was 
worn throughout testing to collect respiratory gases via 
the Parvo Medics TrueMax2400 Metabolic System (Parvo 
Medics, Salt Lake City, UT). Resting respiratory gases were 
taken for 3 to 5 minutes while the subject was seated in a 
resting position on the ergometer. Subjects then immedi-
ately began a 3- to 5-minute warm-up at a low intensity (25 
W) on the electric cycle ergometer.
The Vo
2max
 testing protocol consisted of the YMCA sub-
maximal test as described by the American College of Sports 
Medicine (ACSM) guidelines.19 The YMCA protocol was 
chosen as a means to predict Vo
2max
 based on recommenda-
tions in the literature and to ensure subject safety.2,15,19 All 
subjects began the first 3 minute stage at 25 W. HR was 
recorded during the last 15 seconds of the second and third 
minute of each stage whereas the rate of perceived exertion 
(RPE) was recorded during the last 30 seconds of each stage 
using Borg’s (6-20) scale. The workload of the second stage 
was determined by the steady-state HR attained in the first 
stage as reported in the literature.19 The exercise test contin-
ued until the subject completed 2 stages in which their HR 
was between 110 bpm and 70% of their HRR. The exercise 
test was also terminated if a subject obtained a HR > 150 
bpm, they could not maintain the workload, the subject 
requested to stop, or the investigator felt that the test should 
be terminated for safety reasons. Immediately after the exer-
cise test was completed the workload was reduced to 20 W 
for a cool down of 3 to 5 minutes. During the cool-down 
period the subjects were able to remove the facemask and 
consume fluids ad libitum. Vital signs were continually mon-
itored throughout the recovery period and the subjects were 
able to stop pedaling and dismount the ergometer when vitals 
had appreciably decreased and stabilized. Subjects were 
cleared to leave the laboratory when HR was ≤ 100 bpm, 
systolic BP was within 20 mm Hg of resting values, Spo
2
 was 
within 5% of resting values, and showed no other signs of 
distress or discomfort.
Workload Calculations
Based on the results of the Vo
2max
 prediction test, the sub-
ject’s predicted maximal workloads were determined using a 
regression equation of workload versus HR response.19 
This workload was then used to predict Vo2max using the 
ACSM equation: Leg cycling Vo
2
 (mL/kg/min) = [1.8 × 
work rate (kg m/min)]/body mass (kg) + 3.5 (mL/kg/min) + 
3.5 (mL/kg/min).19 A regression of actual/predicted work-
loads and Vo
2
 values was used to prescribe workloads for 
submaximal exercise sessions.
Submaximal Exercise Sessions
Each subject completed 3 submaximal exercise sessions 
that corresponded with 40% (low intensity), 60% (moderate 
intensity), and 70% (high intensity) of their predicted 
Vo
2max
.These intensities were chosen to correspond with the 
earlier work of Evan et al,15 and because of the range rep-
resenting what values are typically encountered in exercise 
programs with cancer patients. The 3 exercise sessions were 
randomly assigned to each subject in an attempt to mini-
mize confounding outcomes. Subjects returned 2 to 7 days 
after the Vo
2max
 test to begin their submaximal exercise 
sessions.
Once at the laboratory, subjects were fit with a HR moni-
tor and sat upright in a resting position for 5 to 10 minutes. 
During this rest period, subjects were prompted by the 
investigator to complete a 24-hour recall of their diet. The 
information from the dietary recall was entered into the 
website http://www.sparkpeople.com to determine total 
caloric intake, percentage of carbohydrate consumed, and 
percentage of fat consumed in the previous 24 hours. This 
was performed to ensure that the subjects were in a euca-
loric state and that their carbohydrate intake was within a 
normal range of 45% to 55% of daily caloric intake.20 The 
investigator also confirmed that the subjects had been fast-
ing for the past 2 hours and documented any changes in the 
subject’s menstrual status. Next, detailed information 
regarding testing equipment and exercise protocol were 
reviewed with the subject. Resting HR, BP, and Spo
2
 were 
then recorded, and just as with the Vo2max test, the exercise 
session did not progress forward if HR ≥ 100 bpm, systolic 
BP ≥ 140 mm Hg, diastolic BP ≥ 90 mm Hg, or Spo
2
 ≤ 90% 
were observed. A resting blood lactate and blood glucose 
sample were then taken using a finger puncture technique 
and immediately analyzed (described in the Blood Analysis 
section).
The subject then positioned themselves on the electric 
cycle ergometer and secured the facemask tightly around 
their head to collect resting metabolic data for 3 to 5 minutes. 
Once the respiratory gas calorimetry system had stabilized, 
the subject then began a 3- to 5-minute warm-up period at 20 
W on the ergometer. Exercise sessions were based on recom-
mendations in the literature and consisted of 9 minutes of 
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steady-state exercise at the randomly chosen prescribed 
workload for the day and started immediately after the warm-
up.2,15 All subjects were blinded to the specific exercise 
workload for each session. Respiratory gases were collected 
continuously throughout the exercise sessions. The HR and 
RPE were taken during the last 15 seconds of every minute 
during the exercise session to ensure safety.
Following the submaximal exercise, the workload was 
reduced to 20 W for an active recovery of 2 minutes and the 
facemask was removed. After 2 minutes of active recovery 
the subjects were asked to stop pedaling and remain seated 
on the cycle ergometer. A final blood lactate and blood glu-
cose measurement were taken during the last 30 seconds of 
the third minute into recovery. Once the last blood sample 
had been taken, the subjects were able to consume fluids 
and dismount the cycle ergometer. Vital signs were contin-
ually monitored throughout the recovery period and the 
subjects were cleared to leave the laboratory when HR was 
≤ 100 bpm, BP was within 20 mm Hg of resting values, 
Spo
2
 was within 5% of resting values, and subjects were 
showing no other signs of distress or discomfort. The same 
protocol was repeated for the other 2 exercise intensities, 
with at least 48 hours between sessions, over the next 2 
weeks.
Blood Analysis
Finger punctures were used throughout the testing for blood 
analysis. For resting measurements, the fingertip was 
placed in a cup of warm water to increase blood flow to the 
area. The fingertip was dried and then cleaned with an alco-
hol pad and then wiped with a sterile gauze pad to remove 
any residue of sweat or alcohol. A lancet device was used 
for the skin puncture and the finger was gently massaged 
distally until a small bead of blood appeared. A blood lac-
tate measurement was taken first and a blood glucose mea-
surement was taken immediately afterward from the same 
site. Duplicate determination blood samples were obtained 
whenever possible and averaged to represent values.21 The 
finger puncture was then covered with a sterile gauze pad 
and the subject was asked to apply compression for about 1 
to 2 minutes or until bleeding stopped. These steps were 
replicated for the resting and postexercise blood sampling. 
A “Lactate Plus” lactate analyzer (Nova Biomedical, 
Waltham, MA) was used for all blood lactate measure-
ments. Tests in our laboratory indicated this was a highly 
reliable (intraclass correlation coefficient >.90) and valid 
(±0.2 mmol/L) unit. A “One Touch Ultra” glucometer 
(Lifescan, Inc, Milpitas, CA) was used for all blood glu-
cose measurements. All appro priate and necessary quality 
control steps were taken in the han dling and processing 
of blood samples as recommended in the literature in 
order to assure viable specimens.21
Respiratory Gas Analysis
Both the oxygen consumption (Vo
2
) and respiratory 
exchange ratio (RER) were averaged for the last 5 minutes 
(minute 4 to minute 9) of the 40%, 60%, and 70% Vo
2max
 
exercise sessions. If the subject did not complete all 9 
minutes, only the minutes completed after minute 4 were 
averaged. Based on these averages, the amount of calories 
expended per minute was calculated. The RER data was 
then broken down into the percent of fats and carbohy-
drates oxidized per minute.22,23 Finally, the total amount 
of grams oxidized per minute for each substrate was cal-
culated for the 5-minute steady-state period.22,23
Statistical Analysis
All statistical procedures were performed using version 
17.0 of Statistical Package for the Social Sciences (SPSS) 
software (SPSS Inc, Chicago, IL). Statistical significance 
was set a priori at an α level of P ≤ .05. A one-way analysis 
of variance (ANOVA) was performed to compare the 
physical characteristics of the treatment and control groups. 
For the metabolic data, a 2 × 3 mixed model ANOVA 
(group × intensity) was used to examine the effect of group 
and intensity on the rate of fat and carbohydrate oxidation 
(g/min) averaged over the last 5 minutes of steady-state 
submaximal exercise sessions. A Tukey honestly significant 
difference (HSD) post hoc test was used to determine mean 
differences when a significant effect was found. A 2 × 3 
× 2 mixed model ANOVA (group × intensity × time) was 
used to examine the effect of group, intensity and time on 
blood lactate and blood glucose measurements. A Tukey 
HSD post hoc test was used to determine mean differences 
if a significant effect was found. A Pearson product 
moment correlation was performed to examine the relation-
ship between carbohydrate oxidation and recovery blood 
lactate across all 3 exercise intensities within each of the 
groups. A Hotelling test was applied between groups to 




There were 14 subjects who participated in the study; 7 
women in the treatment group and 7 women in the control 
group. All women in the treatment group had been diag-
nosed with breast cancer, had undergone surgery, and had 
completed their major medical treatments (chemotheraphy 
and radiation therapy) within the past 6 months. One 
woman had been diagnosed with stage I breast cancer 
whereas 3 women had been diagnosed with stage II, and 3 
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had been diagnosed with stage III breast cancer. Four of the 
women received both chemotherapy and radiation treat-
ment, whereas 1 woman received only chemotherapy and 2 
women received only radiation therapy as their major 
medical treatments. Six out of the 7 women in the treatment 
group were also on adjuvant therapies (ie, herceptin, 
tamoxifen, femara) during this research study. All women 
in the control group had no history of any preexisting major 
medical conditions that affected their health and all had 
been essentially sedentary for the past year.
The subject groups were matched on physical character-
istics, which are reported in Table 1. There were no signifi-
cant differences (P > .05) between the groups in their 
physical characteristics. Furthermore, the groups did not 
differ (P > .05) on their physical activity level or meno-
pausal status (Table 1).
Subjects were asked to consume their typical diet over 
the course of the research study and a 24-hour dietary recall 
was administered before each submaximal exercise session 
to confirm dietary intakes. There were no significant differ-
ences (P > .05) for total caloric intake, percentage of carbo-
hydrate consumed, or percentage of fats consumed between 
groups before each of the submaximal exercise sessions 
(ranges for caloric intake = 2207-1940 vs 1878-1479 kcal/d; 
carbohydrate intake = 53%-51% vs 57%-52%; fat intake = 
33%-28% vs 34%-28%; for treatment vs control groups, 
respectively).
Exercise Responses
The results of the Vo
2max
 prediction test are reported in 
Table 2. Table 2 also displays the calculated workloads to 
elicit the low, moderate, and high submaximal exercise ses-
sions for each of the subjects. The predicted Vo
2max
, pre-
dicted maximal workload (Wkld
max
), and workloads at all of 
the submaximal exercise intensities were not significantly 
different between groups (P > .05).
During the submaximal exercise sessions there was a 
significant (P ≤ 0.05) effect of intensity on both steady-state 
HR and RPE responses; however, there was no significant 
Table 1. Subject Physical Characteristics, Physical Activity Level, and Menopausal Statusa
Group Age (y) Height (cm) Weight (kg) BMI (kg/m2) Body Fat (%)
Activity Level 
(MET h/wk)
Menopausal Status  
(No. of Women)
Treatment 50.6 ± 3.3 166.5 ± 2.6 81.6 ± 4.2 29.4 ± 1.1 31.8 ± 1.6 77 ± 6 Pre = 1
 Peri = 3
 Post = 3
Control 50.9 ± 3.6 162.8 ± 1.6 75.4 ± 5.4 28.2 ± 1.9 31.2 ± 2.2 65 ± 10 Pre = 3
 Peri = 2
 Post = 2
Note: BMI = body mass index; MET = metabolic equivalent task.
aData are presented as mean ± standard error.
Table 2. Estimated Maximal Oxygen Consumption (Aerobic 
Capacity; Vo
2max
), Maximal Workload (Wkld
max
), and Workload 





























Treatment 22.0 ± 1.5 108 ± 6 39 ± 4 61 ± 4 75 ± 5
Control 24.1 ± 1.7 115 ± 10 43 ± 4 69 ± 5 79 ± 6
aData are presented as mean ± standard error.
difference between HR responses (mean ± standard error 
[SE]) for the treatment group (120 ± 6, 130 ± 5, 147 ± 5 
bpm) versus the control group (115 ± 4, 135 ± 4, 145 ± 4 
bpm; P > .05) group at the low, moderate, and high sub-
maximal exercise intensities, respectively. Similarly, RPE 
responses (mean ± SE) for the treatment group (11 ± 1, 13 
± 1, 14 ± 1 Borg units) versus the control group (10 ± 1, 12 
± 1, 14 ± 1 Borg units; P > .05) did not differ at the low, 
moderate, and high submaximal exercise intensities, 
respectively.
Based on the steady-state Vo
2
 responses achieved by the 
subjects in each of the groups for the low-, moderate-, and 
high-intensity exercise, the actual percentage of Vo
2max
 were 
calculated. These percentages did not differ significantly (P 
> .05) between the groups at each of the various respective 
intensities examined and were in line with desired prescribed 
intensities (40%, 60%, and 70% Vo
2max
).
There was a significant (P < .05) effect of exercise inten-
sity for both carbohydrate and fat oxidation rates at steady-
state exercise (see Figure 1). As exercise intensity increased 
there was greater carbohydrate oxidation rates and decreased 
fat oxidation rates. There was also a significant between 
groups effect for both carbohydrate and fat oxidation rates 
(Figure 1). That is, the treatment group oxidized significantly 
less carbohydrate and significantly more fat across all exer-
cise intensities when compared with the control group.
There was a significant interaction effect for exercise 
intensity and time (ie, preexercise vs postexercise) on the 
Tosti et al. 11















































Figure 1. Steady-state carbohydrate (CHO) and fat oxidation 
rates at different submaximal exercise intensities (mean ± SE; 
Mod, moderate intensity; Tx, treatment group).  The treatment 
group (patients with cancer) had higher fat oxidation and lower 
CHO oxidation rates across all exercise intensities than the 
control group.
























Treatment (Pre) Treatment (Post) Control (Pre) Control (Post)
Figure 2. Preexercise and postexercise blood lactate values 
at different submaximal exercise intensities (mean ± SE; Mod, 
moderate intensity). The treatment group (patients with cancer) 
had lower lactate responses to exercise at all exercise intensities 
than the control group
blood lactate responses to the submaximal exercise sessions 
(P < .05). Specifically, the postexercise lactate response 
became greater as exercise intensity increased in both 
groups (Figure 2); but a lower concentration of blood lac-
tate in response to the exercise was observed (ie, postexer-
cise) across all submaximal exercise sessions in the treatment 
group compared to the control group (P < .05).
The blood glucose responses to exercise approached sig-
nificance (P = .079) for an interaction of group, exercise 
intensity, and time. In this case, the control group tended to 
have lower resting glucose and a more pronounced and con-
sistent decreases in glucose concentrations postexercise 
than the treatment group across all exercise intensities (see 
Figure 3).
Carbohydrate oxidation and postexercise blood lactate 
responses were significantly correlated (P < .05) within 
both the treatment (r = .549) and control groups (r = .635). 
Although there was a stronger correlation in the control 
group, it was not significantly different (P > .05) from the 
treatment group coefficient (see Figures 4 and 5).
None of the women in either group displayed or reported 
any adverse events because of the exercise sessions. 
However, 2 subjects (one in each group) requested to stop 
exercise because of general fatigue before completing all 9 
minutes of the high-intensity (70% Vo
2max
) exercise session. 
These subjects did reach a steady-state reponse and only 
those values were used in all analysis/calculations.
Discussion
The general objective of this study was to develop a better 
understanding of energy metabolism at different exercise 
intensities in posttreated patients with breast cancer com-
pared with healthy women. The goal of obtaining this 
information was to provide insight into aspects of the 
physiological and metabolic responses to exercise in 
patients with breast cancer in order to ultimately aid in the 
development of more accurate and precise exercise pre-
scriptions for such patients.
The subjects recruited into both groups of this study 
were predominantly sedentary in nature. This fact is con-
firmed by the predicted Vo
2max
 in each group; treatment 
group = 22.0 ± 1.5 mL/kg/min, and control group = 24.1 ± 
1.7 mL/kg/min. According to the ACSM, these outcomes 
classify the groups at low levels of aerobic physical 
fitness.19
The subjects of each group responded appropriately to all 
submaximal exercise sessions. Specifically, there was a sig-
nificant increase in Vo
2
, RER, HR, and RPE from rest to exer-
cise during all submaximal exercise sessions in both groups. 
Both groups also elicited significantly greater increases in Vo
2
, 
RER, HR, and RPE during exercise as the intensity of the sub-





) to high (70% Vo
2max
). Such findings are in 
agreement with the physiological responses to exercise in 
healthy persons and patients with cancer.11,15,19
Blood lactate levels also increased from rest to postexer-
cise in all sessions and the responses became significantly 























Treatment (Pre) Treatment (Post) Control (Pre) Control (Post)
HighLow Mod
Figure 3. Preexercise and postexercise blood glucose values 



























Figure 4. Correlation between carbohydrate oxidation rate and 
postexercise blood lactate response (P < .05) at all submaximal 





























Figure 5. Correlation between carbohydrate oxidation rate and 
postexercise blood lactate response (P < .05) at all submaximal 
exercise intensities in the control group.
greater as the exercise sessions became more intense. This 
type of response agrees with previous findings.11,15 
However, there was a significantly lower overall response 
in blood lactate to exercise in the treatment group compared 
with the control group. This finding agrees in part with the 
work of Evans and associates.15 In their study, the lactate 
responses of cancer patients were significantly less than 
that of healthy control subjects only after high-intensity 
exercise (~70% Vo
2max
). Why the results of Evans et al and 
the present study are somewhat conflicting is uncertain. 
These differences may be attributed to the mode of exercise 
(treadmill vs cycle ergometer; which can have differing 
type of muscle fiber recruitment pattern), the subject group 
characteristics relative to training level status, or the small 
sample sizes used in each of the studies. Regardless of these 
differences, there is evidence in both studies for decreased 
blood lactate accumulation during exercise in patients with 
breast cancer when compared with healthy women.
The findings of lower postexercise lactate responses at 
all exercise intensities (low, moderate, and high) in patients 
with cancer is a new and novel finding. These lower lactate 
responses in the cancer group are in line with the reduced 
carbohydrate oxidation and greater fat oxidation found in 
this group compared with the control group across all the 
exercise intensities. This finding concerning substrate oxi-
dation is also a new and novel finding. These physiological 
events for lactate and oxidation are in agreement; that is, if 
less carbohydrate is being oxidized, then a reduced amount 
of lactate should be produced.24,25 It is well established that 
as exercise intensity increases there is a greater reliance on 
carbohydrate and a reduction in fat as an energy source, 
which was observed in both study groups.11,24 But, the find-
ing of between-group differences in the magnitude of the 
oxidation rates of carbohydrate and fat has never been pre-
viously reported in the literature. It is unknown specifically 
whether this reduced oxidation of carbohydrate in the can-
cer group is producing the reduced lactate responses in the 
blood because (a) the substrate glucose is unavailable to 
the skeletal muscle, (b) there is a reduced glucose uptake 
mechanism within the muscle, or (c) perhaps the biochemi-
cal pathway glycolysis or related controlling factors within 
the muscle is compromised. These last points cannot be 
determined from the present data but are in need of evalua-
tion within future studies.
Why carbohydrate oxidation is reduced and fat oxidation is 
enhanced during exercise in the patients with cancer is uncer-
tain too. Some of the possibilities may be related to preexisting 
conditions (such as increased adiposity and menopausal status) 
the actual cancer disease process itself or side effects of the 
anticancer treatments administered to the subjects in the treat-
ment group. Although all of the women were considered 
healthy (other than breast cancer in the treatment group), some 
women within each group were also classified as overweight, 
obese, or menopausal. Metabolic alterations have been 
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displayed in overweight and obese populations, which may 
increase lipolysis.26 During exercise, obese populations have 
blunted sympathetic nervous system and catecholamine 
responses, which may alter the extent of lipolysis occurring; 
however the rate of fat oxidation does not seem to differ 
between obese and normal weight individuals.26 Figure 1 indi-
cates, however, that there was a significant difference in the 
rate of fat oxidation between groups. The difference in fat oxi-
dation observed does not seem attributable to adiposity related 
factors since there were no differences in BMI or body fat per-
centage between the groups (Table 1).
Women who have begun menopause begin to produce 
less estrogen from their ovaries, which can affect energy 
metabolism.26,27 Lower levels of circulating estrogen are 
associated with increased carbohydrate oxidation and blood 
lactate responses during exercise; that is, opposite of what 
was seen in the treatment group.26,27 The results of this 
study show that there was no significant difference between 
groups for menopausal status; although there were slightly 
more menopausal women in the treatment group than the 
control group. Therefore, a highly divergent menopausal 
status between the groups would also not seem to explain 
the difference in fat and carbohydrate oxidation observed 
between the groups.
The disease process of cancer has been associated with 
endocrine changes that may affect metabolism.12,13,28,29 For 
example, Sommers29 found that the majority of patients with 
breast cancer presented with endocrine abnormalities; in 
particular, the pituitary and ovary glands were found to be in 
a hyperfunctional state. It is believed that these abnormal 
endocrine gland actions cause an increase in estrogen 
release from either the ovaries or the adrenal cortex, which 
is stimulated through the pituitary–adrenal pathway.29 
Estrogen can directly and indirectly increase lipolysis and 
fat oxidation both at rest and during exercise.27 However, 
the role of cancer-associated endocrine changes on glucose 
metabolism in the context of this study is speculation on our 
part since hormonal measurements were not performed.
The disease state of cancer has also been associated 
with mild to moderate hyperglycemia, glucose intolerance, 
and insulin resistance, which may affect energy metabolism 
too.12,13,28 There was no significant difference between 
groups for resting blood glucose in the current study, which 
is consistent with some previous literature.12,13 However, 
resting levels of blood glucose did tend to be slightly higher 
in the cancer treatment group compared with the control 
group. Interestingly, there was a tendency for less of a 
decrease in blood glucose after exercise in the treatment 
group when compared with the control group (Figure 2). 
Although these glucose findings only approached signifi-
cance (P < .08), they nonetheless support the concept of 
glucose intolerance in cancer populations, which could be 
driven in part by a developing insulin resistance.12,13,28 
Perhaps to some degree this effect is persisting even into 
exercise within the cancer patients and compromises their 
ability to metabolize carbohydrate. Again, this is only spec-
ulation and would need to be confirmed with an oral glu-
cose tolerance test and hormonal measurements, which were 
not possible in the current study.
Specific cancer treatments may also be affecting metabo-
lism in these patients with breast cancer. The goal of cancer 
treatments is to destroy cancerous tissues and cells.30 
Radiation therapy is localized and destroys cancerous cells 
by fracturing their DNA sequence.31 Chemotherapy, antihor-
monal drug treatments such as tamoxifen and femara, and 
biological therapies such as herceptin, are all systemic thera-
pies used to treat breast cancer.31 Although these treatments 
are meant to affect cancerous tissue primarily, they are not 
always selective and healthy systemic tissue may also be 
negatively affected by these harsh treatments causing 
unwanted side effects.30 All the patients with cancer had 
undergone some type of systemic treatments (ie, chemo-
therapy, antihormonal therapy, biological therapy) and 
some of them were undergoing hormonal therapy at the time 
of the study. It is highly possible that when these systemic 
treatments target the cancer cells and destroy their metabolic 
process, some healthy cells are also affected. Decreasing car-
bohydrate metabolism ability within the cancer cell is 
essential to destroy the tumor but consequently it can be 
detrimental to healthy cells attempting to produce energy 
from carbohydrate during exercise.
Most of the patients (5 out of 7) in the current study were 
also receiving antihormonal therapies such as tamoxifen 
or drug agents that mimic tamoxifen. Although tamoxifen 
works against the harmful actions of estrogen at breast tis-
sue, it actually acts in the same way as estrogen at many 
other tissues in the human body.32 As stated earlier, 
increased amounts of circulating estrogen has both a direct 
and indirect effect on increasing fat metabolism and inhibi-
tion of carbohydrate metabolism.27 Not only does estrogen 
have direct effects on lipolysis, it may also directly reduce 
glucose uptake in the muscle.26 The current results support 
this concept through the observed decreased carbohydrate 
oxidation as well as the tendency for less of a reduction in 
blood glucose in the cancer group during exercise.
Exogenous estrogens, such as oral contraceptives or 
hormonal therapies, can also have indirect effects on sub-
strate oxidation. Bunt27 has reported that estrogen can 
result in increased levels of cortisol, a result of estrogen 
stimulating the adrenal cortex. In addition, tamoxifen has 
been shown to substantially increase plasma cortisol con-
centrations in patients with breast cancer.33 Cortisol is a 
powerful lipolytic hormone and is connected to increased 
fat metabolism at rest and during exercise.34 The resulting 
lipolysis from cortisol elevation can be further enhanced 
through estrogen (or tamoxifen acting like estrogen), by its 
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action of promoting growth hormone (hGH) release from 
the anterior pituitary.27 Growth hormone is likewise known 
to promote lipolysis and free fatty acid mobilization at rest 
and in response to exercise.27,34 Furthermore, these actions of 
cortisol and hGH can promote a reduction in glycogenolysis, 
which in turn decreases glycolytic substrate availability and 
lactate production.26,27
Additionally, estrogens have been shown to result in a 
chronic elevation of the insulin:glucagon (I:G) ratio, 
which further reduces the rate of glycogenolysis.26,27,34 Such 
actions on the I:G ratio can lead to decreased insulin sensi-
tivity, promote glucose intolerance and hyperglycemia.27 
Changes in glucose tolerance have been observed in 
women who receive exogenous estrogen through oral 
contraceptives or hormone replacement therapy.27 
Furthermore, women using exogenous estrogen have exhib-
ited higher blood glucose levels, greater hGH and cortisol 
responses, and slightly greater fat oxidation and reduced 
glycogenolysis during submaximal exercise when compared 
with women not using exogenous estrogen.27
Thus, chemotherapy treatments and the use of tamoxifen-
like drugs may be compounding this myriad of events to 
further disrupt normal energy metabolism in patients with 
cancer during exercise. This means that some drug thera-
pies used by these patients may contribute in part to their 
altered energy metabolism during exercise which promotes 
the reduced lactate responses observed in this study. 
Obviously, without hormonal measurements from this 
study to confirm this hypothesis, the above must be consid-
ered speculation. Nonetheless, this does provide a plausible 
explanation for the metabolic findings in the study.
Practical Implications
The present results combined with those of Evans et al15 
suggest that blood lactate responses postexercise are not a 
good indicator of exercise intensity in patients with breast 
cancer, especially at higher intensities (≥70% Vo
2max
). 
This is contrary to findings in normal healthy individuals 
where lactate responses are used as accurate indictors of 
exercise intensity.11 Furthermore, the ability to produce 
energy from carbohydrate metabolism during exercise is 
significantly diminished in patients with breast cancer 
compared with healthy women. Since glucose and glyco-
gen (ie, carbohydrate) are the predominant choices 
for energy production during high-intensity exercise, 
this diminished capacity has implications for exercise 
prescription for this select group. Clinicians should under-
stand that energy cannot be produced as rapidly through 
anaerobic–aerobic glycolytic means in these patients, making 
exercise at higher intensities more challenging to perform. 
Relative to exercise prescription, additional research is 
necessary to determine what are the most appropriate 
physiological choice (lactate, HR, RPE, etc) for the moni-
toring of aerobic exercise intensity in posttreated patients 
with breast cancer. However, the present data do call into 
question the validity of lactate response measurements in 
this clinical population.
Conclusion
In summary, this study showed that there is a reduced blood 
lactate response, decreased carbohydrate oxidation rate, and 
increased fat oxidation rate in patients with breast cancer 
during exercise, which may compromise their capacity to 
perform higher intensity exercise. These findings need to 
be considered preliminary in nature because of the small 
sample size used. Regardless, these results are striking, and 
much more research needs to be performed to replicate, 
confirm, and expand on the evidence presented here. 
Clinicians and exercise trainers working with patients with 
breast cancer should keep these physiological limitations 
in mind while developing exercise prescriptions and pro-
grams for such patients. Finally, it is important to note, 
these findings can only be generalized to women who have 
been diagnosed with stage I-III breast cancer and have fin-
ished all of their major medical treatments within the past 6 
months.
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